| Primary |
| Multiple Myeloma |
25.1% |
| Metastases To Bone |
20.5% |
| Breast Cancer |
16.5% |
| Breast Cancer Metastatic |
5.8% |
| Pain |
5.7% |
| Osteoporosis |
4.6% |
| Depression |
3.3% |
| Hypertension |
3.2% |
| Prophylaxis |
2.4% |
| Neoplasm Malignant |
1.7% |
| Hypercalcaemia |
1.6% |
| Anxiety |
1.5% |
| Anaemia |
1.4% |
| Prostate Cancer |
1.3% |
| Arthritis |
1.0% |
| Chemotherapy |
1.0% |
| Gastrooesophageal Reflux Disease |
0.9% |
| Insomnia |
0.8% |
| Plasma Cell Myeloma |
0.8% |
| Resorption Bone Increased |
0.8% |
|
| Tooth Extraction |
18.7% |
| Weight Decreased |
13.0% |
| Osteonecrosis |
12.3% |
| Pain |
12.0% |
| Vomiting |
4.7% |
| Wound Drainage |
4.6% |
| Toothache |
3.7% |
| X-ray Abnormal |
3.6% |
| Wound Dehiscence |
3.3% |
| Osteonecrosis Of Jaw |
3.1% |
| Wheezing |
2.9% |
| Wound Debridement |
2.8% |
| Weight Increased |
2.8% |
| Tooth Loss |
2.3% |
| White Blood Cell Count Increased |
1.8% |
| Pain In Jaw |
1.7% |
| Wound Secretion |
1.7% |
| Wound Treatment |
1.7% |
| Wheelchair User |
1.7% |
| Swelling |
1.6% |
|
| Secondary |
| Multiple Myeloma |
21.1% |
| Metastases To Bone |
20.9% |
| Breast Cancer |
12.4% |
| Osteoporosis |
7.6% |
| Pain |
6.9% |
| Breast Cancer Metastatic |
5.2% |
| Depression |
3.9% |
| Hypercalcaemia |
2.8% |
| Bone Loss |
2.5% |
| Anaemia |
2.4% |
| Hypertension |
2.4% |
| Nausea |
1.8% |
| Muscle Spasms |
1.7% |
| Anxiety |
1.6% |
| Sleep Disorder |
1.5% |
| Arthritis |
1.4% |
| Plasma Cell Myeloma |
1.3% |
| Breast Cancer Recurrent |
1.0% |
| Chemotherapy |
0.9% |
| Bone Disorder |
0.9% |
|
| Weight Decreased |
19.5% |
| Tooth Extraction |
17.2% |
| Osteonecrosis |
9.0% |
| Vomiting |
6.8% |
| Toothache |
5.5% |
| Osteonecrosis Of Jaw |
4.4% |
| Wound Debridement |
3.6% |
| Tooth Loss |
3.5% |
| Vision Blurred |
3.2% |
| Wheezing |
3.0% |
| X-ray Abnormal |
3.0% |
| Wound Drainage |
2.9% |
| Wound Infection Staphylococcal |
2.7% |
| Weight Increased |
2.6% |
| White Blood Cell Count Increased |
2.4% |
| Pain |
2.4% |
| White Blood Cell Count Decreased |
2.4% |
| Swelling |
2.1% |
| Wound |
2.0% |
| Vertebroplasty |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.5% |
| Multiple Myeloma |
22.9% |
| Drug Use For Unknown Indication |
22.3% |
| Pain |
5.4% |
| Hypertension |
3.4% |
| Breast Cancer |
2.8% |
| Plasma Cell Myeloma |
2.4% |
| Breast Cancer Metastatic |
2.2% |
| Constipation |
1.9% |
| Prophylaxis |
1.9% |
| Nausea |
1.8% |
| Metastases To Bone |
1.8% |
| Osteoporosis |
1.4% |
| Prostate Cancer |
1.3% |
| Non-small Cell Lung Cancer |
1.0% |
| Insomnia |
0.9% |
| Bone Disorder |
0.8% |
| Infection |
0.8% |
| Back Pain |
0.8% |
| Vomiting |
0.7% |
|
| Thrombocytopenia |
11.0% |
| White Blood Cell Count Decreased |
9.7% |
| Death |
9.4% |
| Weight Decreased |
8.8% |
| Vomiting |
8.0% |
| Fatigue |
5.8% |
| Pneumonia |
5.0% |
| Pyrexia |
5.0% |
| Multiple Myeloma |
4.7% |
| Rash |
4.1% |
| Neutropenia |
3.6% |
| Renal Failure |
3.3% |
| Neuropathy Peripheral |
3.0% |
| Diarrhoea |
2.8% |
| Muscle Spasms |
2.8% |
| Nausea |
2.8% |
| Pancytopenia |
2.8% |
| Urinary Tract Infection |
2.8% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.5% |
| Disease Progression |
2.2% |
|
| Interacting |
| Multiple Myeloma |
29.0% |
| Sepsis |
12.9% |
| Ear Tuberculosis |
9.7% |
| Anxiety |
6.5% |
| Bone Cancer Metastatic |
6.5% |
| Breast Cancer Metastatic |
6.5% |
| Depression |
6.5% |
| Hypertension |
6.5% |
| Langerhans' Cell Histiocytosis |
6.5% |
| Prophylaxis |
6.5% |
| Infection Prophylaxis |
3.2% |
|
| Urticaria |
40.0% |
| Pyrexia |
30.0% |
| Sepsis |
20.0% |
| White Blood Cell Count Increased |
10.0% |
|
